Literature DB >> 11076682

IGF-II promotes mesoderm formation.

O G Morali1, A Jouneau, K J McLaughlin, J P Thiery, L Larue.   

Abstract

IGF-II is abundant in the nascent mesoderm of the gastrulating mouse embryo. Its function at this developmental stage is unknown. We investigated it by following the in vitro and in vivo differentiation of several androgenetic, biparental, parthenogenetic, and androgenetic Igf2 -/- murine ES cell lines; these cells differed in endogenous IGF-II levels because Igf2 is paternally expressed in the mouse embryo in most tissues. The expression of mesoderm markers and the subsequent formation of muscle structures were correlated with endogenous IGF-II level during teratoma formation and during in vitro differentiation. In addition, the absence of Igf2 in androgenetic Igf2 -/- ES cells led to a severe impairment of mesoderm development, demonstrating the dependence of the preferential mesoderm development of androgenetic ES cells upon Igf2 activity, among the numerous known imprinted genes. The addition of exogenous IGF-II to in vitro differentiation culture medium led to a specific increase in the expression of mesoderm markers. Thus, we propose a novel model in which the binding of IGF-II to its principal signaling receptor, IGF1R, at the surface of mesoderm precursor cells increases the formation of mesoderm cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076682     DOI: 10.1006/dbio.2000.9875

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  20 in total

Review 1.  Cardiac repair by embryonic stem-derived cells.

Authors:  M Rubart; L J Field
Journal:  Handb Exp Pharmacol       Date:  2006

2.  In vivo and in vitro differentiation of uniparental embryonic stem cells into hematopoietic and neural cell types.

Authors:  Sigrid Eckardt; Timo C Dinger; Satoshi Kurosaka; N Adrian Leu; Albrecht M Müller; K John McLaughlin
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

Review 3.  Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis.

Authors:  Maria Grazia Perino; Satoshi Yamanaka; Jinliang Li; Anna M Wobus; Kenneth R Boheler
Journal:  J Mol Cell Cardiol       Date:  2008-05-11       Impact factor: 5.000

4.  Refinement of cytokine use in the in vitro expansion of erythroid cells.

Authors:  Ken-Ichi Miharada; Takashi Hiroyama; Kazuhiro Sudo; Toshiro Nagasawa; Yukio Nakamura
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

5.  Comparative analysis of nuclear transfer embryo-derived mouse embryonic stem cells. Part I: cellular characterization.

Authors:  Julianna Kobolak; Solomon Mamo; Ruttachuk Rungsiwiwut; Olga Ujhelly; Erika Csonka; Gyula Hadlaczky; Andras Dinnyes
Journal:  Cell Reprogram       Date:  2011-12-28       Impact factor: 1.987

Review 6.  Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.

Authors:  Ann Peters; Paul W Burridge; Marina V Pryzhkova; Michal A Levine; Tea-Soon Park; Christopher Roxbury; Xuan Yuan; Bruno Péault; Elias T Zambidis
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

7.  Phenotype and Stability of Neural Differentiation of Androgenetic Murine ES Cell-Derived Neural Progenitor Cells.

Authors:  Wanja Wolber; Ruhel Ahmad; Soon Won Choi; Sigrid Eckardt; K John McLaughlin; Jessica Schmitt; Christian Geis; Manfred Heckmann; Anna-Leena Sirén; Albrecht M Müller
Journal:  Cell Med       Date:  2013-06-13

8.  Insulin-like growth factor promotes cardiac lineage induction in vitro by selective expansion of early mesoderm.

Authors:  Marc C Engels; Kuppusamy Rajarajan; Rebecca Feistritzer; Arun Sharma; Ulrik B Nielsen; Martin J Schalij; Antoine A F de Vries; Daniël A Pijnappels; Sean M Wu
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277

9.  GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion.

Authors:  Sherry Wanderling; Birgitte B Simen; Olga Ostrovsky; Noreen T Ahmed; Shawn M Vogen; Tali Gidalevitz; Yair Argon
Journal:  Mol Biol Cell       Date:  2007-07-18       Impact factor: 4.138

10.  A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes.

Authors:  Josep M Mercader; Rachel G Liao; Avery D Bell; Zachary Dymek; Karol Estrada; Taru Tukiainen; Alicia Huerta-Chagoya; Hortensia Moreno-Macías; Kathleen A Jablonski; Robert L Hanson; Geoffrey A Walford; Ignasi Moran; Ling Chen; Vineeta Agarwala; María Luisa Ordoñez-Sánchez; Rosario Rodríguez-Guillen; Maribel Rodríguez-Torres; Yayoi Segura-Kato; Humberto García-Ortiz; Federico Centeno-Cruz; Francisco Barajas-Olmos; Lizz Caulkins; Sobha Puppala; Pierre Fontanillas; Amy L Williams; Sílvia Bonàs-Guarch; Chris Hartl; Stephan Ripke; Katherine Tooley; Jacqueline Lane; Carlos Zerrweck; Angélica Martínez-Hernández; Emilio J Córdova; Elvia Mendoza-Caamal; Cecilia Contreras-Cubas; María E González-Villalpando; Ivette Cruz-Bautista; Liliana Muñoz-Hernández; Donaji Gómez-Velasco; Ulises Alvirde; Brian E Henderson; Lynne R Wilkens; Loic Le Marchand; Olimpia Arellano-Campos; Laura Riba; Maegan Harden; Stacey Gabriel; Hanna E Abboud; Maria L Cortes; Cristina Revilla-Monsalve; Sergio Islas-Andrade; Xavier Soberon; Joanne E Curran; Christopher P Jenkinson; Ralph A DeFronzo; Donna M Lehman; Craig L Hanis; Graeme I Bell; Michael Boehnke; John Blangero; Ravindranath Duggirala; Richa Saxena; Daniel MacArthur; Jorge Ferrer; Steven A McCarroll; David Torrents; William C Knowler; Leslie J Baier; Noel Burtt; Clicerio González-Villalpando; Christopher A Haiman; Carlos A Aguilar-Salinas; Teresa Tusié-Luna; Jason Flannick; Suzanne B R Jacobs; Lorena Orozco; David Altshuler; Jose C Florez
Journal:  Diabetes       Date:  2017-08-24       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.